Skip to main content
OpenTrials
Completed

NCT Number: NCT05423366

Comparative Effects of Focused and Unfocused (Radial) ESWT in the Treatment of Patellar Tendinopathy.

There is no scientific study in the literature regarding the use of different extracorporeal shock wave therapies (ESWT) in the treatment of patellar tendinopathy. In this study, we aim to investigate both the effectiveness of ESWT and which type of ESWT can be more effective in the treatment of patellar tendinopathy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Patellar Tendinitis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Yuzuncu Yil University

Van, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Engaging in active sports, being 18 years or older, history of activity-related knee pain in the patellar tendon or patellar insertion, symptoms lasting longer than 8 weeks (non-acute), VISA-P score less than 80 before treatment, pain during knee loading on tendon or tendon it remains isolated in the limited part of the bone junction and does not spread to the entire patellar region (to differentiate patellar tendinopathy and patellofemoral pain).

Exclusion criteria

  • Being under the age of 18, acute knee or acute patellar tendon injury, chronic inflammatory joint diseases (rheumatoid arthritis, etc.), using immunosuppressive or corticosteroid medication in the last 6 months, previous knee surgery (in the anterior cruciate ligament or patellar tendon), knee in the last 1 month local (corticosteroid) injection, contraindications for ESWT treatment (eg pregnancy, malignancy, coagulopathy), previous ESWT treatment

Treatment and study plan

Extracorporeal Shock Wave Therapy (ESWT)

Device

The ESWT device is product of Elettronica Pagani, Italy.

Primary outcomes

  1. Visual Analogue Scale (VAS)

    Time frame: at baseline.

    patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse

  2. Visual Analogue Scale (VAS)

    Time frame: 3 weeks after baseline.

    patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse

  3. Visual Analogue Scale (VAS)

    Time frame: 7 weeks after baseline.

    patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse

  4. Visual Analogue Scale (VAS)

    Time frame: 15 weeks after baseline.

    patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse

  5. Victorian Institute of Sports Assessment-Patella (VISA-P)

    Time frame: at baseline.

    The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies. Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire. Scores below 80 are usually indicative of patellar tendinopathy.

  6. Victorian Institute of Sports Assessment-Patella (VISA-P)

    Time frame: 3 weeks after baseline.

    The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies. Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire. Scores below 80 are usually indicative of patellar tendinopathy.

  7. Victorian Institute of Sports Assessment-Patella (VISA-P)

    Time frame: 7 weeks after baseline.

    The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies. Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire. Scores below 80 are usually indicative of patellar tendinopathy.

  8. Victorian Institute of Sports Assessment-Patella (VISA-P)

    Time frame: 15 weeks after baseline.

    The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies. Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire. Scores below 80 are usually indicative of patellar tendinopathy.

Sponsors and collaborators

Lead sponsor

Yuzuncu Yil University

Other

Registry information

Official study title

Comparative Effects of Large Focused and Controlled Unfocused (Radial) Extracorporeal Shock Wave Therapies in the Treatment of Patellar Tendinopathy.

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Jun 21, 2022
Registry last updated
Feb 1, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.